首页 | 本学科首页   官方微博 | 高级检索  
     

雷贝拉唑联合莫沙必利治疗反流性食管炎的疗效观察
引用本文:王雪. 雷贝拉唑联合莫沙必利治疗反流性食管炎的疗效观察[J]. 黑龙江医学, 2011, 35(9): 685-687. DOI: 10.3969/j.issn.1004-5775.2011.09.020
作者姓名:王雪
作者单位:成都中医药大学第二临床医学院内科教研室,四川,成都,611137
摘    要:目的 观察雷贝拉唑联合莫沙必利治疗返流性食管炎的临床疗效.方法 将46例反流性食管炎患者,随机分为治疗组23例和对照组23例,两组均服用莫沙必利,观察组再给予雷贝拉唑.结果 治疗8周后,治疗组症状改善优于对照组,临床疗效总有效率95.6%,两组比较有显著性差异(P<0.05),内镜下疗效观察结果显示:治疗组显著优于对照...

关 键 词:雷贝拉唑  莫沙必利  反流性食管炎  临床疗效

Rabeprazole Joint Mosapride Treatment of Reflux Esophagitis Clinical Observation
WANG Xue. Rabeprazole Joint Mosapride Treatment of Reflux Esophagitis Clinical Observation[J]. Heilongjiang Medical Journal, 2011, 35(9): 685-687. DOI: 10.3969/j.issn.1004-5775.2011.09.020
Authors:WANG Xue
Affiliation:WANG Xue(The Second Clinic of Hospital of the Traditional Chinese Medicine University of Chengdu,Chengdu 611137,CHINA)
Abstract:Objective To observe rabeprazole joint mosapride treatment of reflux esophagitis clinical efficacy.Methods 46 patients with reflux esophagitis patients,randomly divided into treatment group of 23 patients and control group of 23 patients.Both groups were taking mosapride.In the observation group and then give rabeprazole.Results After 8 weeks,symptoms improved treatment group than the control group,clinical total effective rate was 95.6%,the two groups was significant difference(P<0.05).Efficacy of endoscop...
Keywords:Rabeprazole  Mosapride  Reflux esophagitis  Clinical efficacy  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号